|

EXACT SCIENCES CORP (EXAS)

US30063P1057 - Common Stock

65.06  +0.34 (+0.53%)

After market: 65.06 0 (0%)

News Image
6 days ago - InvestorPlace

3 Stocks at the Forefront of Personalized Medicine Trend

Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly

News Image
11 days ago - EXACT SCIENCES CORP

Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...

News Image
11 days ago - EXACT SCIENCES CORP

Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...

News Image
15 days ago - The Motley Fool

A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest

If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right?

News Image
16 days ago - InvestorPlace

The 3 Best Digital Health Stocks for Personalized Medicine

Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.

News Image
20 days ago - Seeking Alpha

Cantor Fitzgerald cuts Mainz to neutral, cites liquidity concerns (NASDAQ:MYNZ)

Cantor Fitzgerald lowered its rating on Mainz Biomed (MYNZ) to neutral, citing concerns that the company will need an additional $25M in capital in next year. Read more here.

News Image
21 days ago - InvestorPlace

3 Biotech Stocks With Big-Time Breakthrough Potential

The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave.

News Image
21 days ago - The Motley Fool

2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030

Don't miss out on these potentially market-beating stocks.

News Image
24 days ago - Seeking Alpha

Exact Sciences sues Geneoscopy for alleged patent infringement (EXAS)

Exact Sciences (EXAS) has filed a lawsuit alleging that Geneocopy's ColoSense infringes upon a key patent for its colorectal cancer test Cologuard. Read more here.

News Image
24 days ago - EXACT SCIENCES CORP

Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that it has filed a lawsuit...

News Image
a month ago - InvestorPlace

3 Stocks to Love Despite All of the Wall Street Hate

We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar. 

News Image
a month ago - InvestorPlace

7 Biotech Stocks to Buy for Big-Time Gains

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

News Image
a month ago - The Motley Fool

Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript

EXAS earnings call for the period ending September 30, 2023.

News Image
a month ago - Investor's Business Daily

Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth

The company makes a diagnostic tool to detect colon cancer.

News Image
a month ago - Exact Sciences Corporation

Exact Sciences Announces Third-Quarter 2023 Results

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated...

News Image
a month ago - Exact Sciences Corporation

Exact Sciences to participate in November investor conferences

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

News Image
2 months ago - Market News Video

RSI Alert: EXACT Sciences (EXAS) Now Oversold

News Image
2 months ago - InvestorPlace

3 Comeback Stocks to Buy Before They Soar Again in 2024

High Treasury yields were triggered by economic growth, not inflation. As a result, there are likely to be many comeback stocks.

News Image
2 months ago - BusinessInsider

3 Comeback Stocks to Buy Before They Soar Again in 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors are probably upset that the yields of the 10-year treasury bonds...

News Image
2 months ago - Investor's Business Daily

Cathie Wood's Biggest Holdings Are Tumbling, Including Tesla

Even Ark Invest's big 2023 winners are well off highs.

News Image
2 months ago - EXACT SCIENCES CORP

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the...

News Image
2 months ago - EXACT SCIENCES CORP

Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will present new data...

News Image
2 months ago - InvestorPlace

7 Winning Stocks That Will Make You an Investing Champion

Inflation is under control and economic growth is strong. Here are seven winning stocks to buy to exploit the positive trends. 

News Image
2 months ago - InvestorPlace

Cathie Wood’s 3 Favorite AI Stocks: October 2023

Despite the surprising sale of her Nvidia stock, investors can still look to Cathie Wood for guidance on future purchases of AI stocks.

News Image
2 months ago - InvestorPlace

7 Affordable Stocks to Invest in as America’s Population Ages

Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors.

News Image
2 months ago - Seeking Alpha

Exact Sciences stock upgraded at Piper Sandler (NASDAQ:EXAS)

Exact Sciences (EXAS) has been upgraded by Piper Sandler, citing an attractive buying opportunity and a high growth potential in cancer screening. Read more here.

News Image
2 months ago - Exact Sciences Corporation

Exact Sciences schedules third quarter 2023 earnings call

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to...